1. Home
  2. EKSO vs ARTL Comparison

EKSO vs ARTL Comparison

Compare EKSO & ARTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EKSO
  • ARTL
  • Stock Information
  • Founded
  • EKSO 2005
  • ARTL 2011
  • Country
  • EKSO United States
  • ARTL United States
  • Employees
  • EKSO N/A
  • ARTL N/A
  • Industry
  • EKSO Medical/Dental Instruments
  • ARTL Biotechnology: Pharmaceutical Preparations
  • Sector
  • EKSO Health Care
  • ARTL Health Care
  • Exchange
  • EKSO Nasdaq
  • ARTL Nasdaq
  • Market Cap
  • EKSO 7.7M
  • ARTL 6.7M
  • IPO Year
  • EKSO N/A
  • ARTL N/A
  • Fundamental
  • Price
  • EKSO $4.04
  • ARTL $1.73
  • Analyst Decision
  • EKSO Strong Buy
  • ARTL Buy
  • Analyst Count
  • EKSO 2
  • ARTL 3
  • Target Price
  • EKSO $7.75
  • ARTL $30.00
  • AVG Volume (30 Days)
  • EKSO 51.6K
  • ARTL 532.3K
  • Earning Date
  • EKSO 10-28-2025
  • ARTL 11-12-2025
  • Dividend Yield
  • EKSO N/A
  • ARTL N/A
  • EPS Growth
  • EKSO N/A
  • ARTL N/A
  • EPS
  • EKSO N/A
  • ARTL N/A
  • Revenue
  • EKSO $14,749,000.00
  • ARTL N/A
  • Revenue This Year
  • EKSO N/A
  • ARTL N/A
  • Revenue Next Year
  • EKSO $49.96
  • ARTL N/A
  • P/E Ratio
  • EKSO N/A
  • ARTL N/A
  • Revenue Growth
  • EKSO N/A
  • ARTL N/A
  • 52 Week Low
  • EKSO $2.73
  • ARTL $1.55
  • 52 Week High
  • EKSO $14.97
  • ARTL $28.60
  • Technical
  • Relative Strength Index (RSI)
  • EKSO 40.70
  • ARTL 24.72
  • Support Level
  • EKSO $3.86
  • ARTL $1.74
  • Resistance Level
  • EKSO $4.32
  • ARTL $1.89
  • Average True Range (ATR)
  • EKSO 0.40
  • ARTL 0.27
  • MACD
  • EKSO -0.13
  • ARTL 0.07
  • Stochastic Oscillator
  • EKSO 15.50
  • ARTL 16.03

About EKSO Ekso Bionics Holdings Inc.

Ekso Bionics Holdings Inc designs, develops and sells exoskeleton technology used in healthcare and industrial markets. The wearable exoskeletons are to be worn over clothes and controlled by a trained operator to augment human strength, endurance, and mobility. The company's segments are Enterprise Health and Personal Health. All of the company's operations are held in the United States. The regions the company operates in are the Americas, EMEA, and APAC.

About ARTL Artelo Biosciences Inc.

Artelo Biosciences Inc is a United States-based development-stage biopharmaceutical company. It is engaged in the development of therapeutics that target lipid signaling pathways, including the endocannabinoid system, a family of receptors & neurotransmitters that form a biochemical communication network in the body. It is focused on discovering, licensing, developing, & commercializing treatments that control endocannabinoid systems. The company pursues technologies & programs that offer proprietary approaches to cannabinoid-based therapies, & those derived from the cannabis plant & synthetic cannabinoids, as well as new chemical entities & compounds. The firm's flagship program is designed to be a patent-protected cannabinoid drug combination treatment for a rare & orphan disease.

Share on Social Networks: